Advancements in personalized medicine and other innovations are transforming the way dosage forms are viewed.

Reshaping Dosage Forms

This study aimed to develop a taste-masked drug resin complex using the ion exchange resin Kyron T-114.

Development of Taste-Masked Oral Dispersible Tablets of Cefpodoxime Proxetil

Novel genetic engineering technologies are transforming the design and manufacture of bispecific antibodies, which are emerging as a promising new class of biologics.

Frontrunners in Bispecific Antibodies

Topic

Articles

Barry Holtz, Principal, at Holtz Biopharma Consulting, and Klyo Collaborative, spoke with Pharmaceutical Technology about collaborative success strategies for biopharm companies.

Collaborative Success Strategies for Biopharm Companies

The new column features Natrix’s signature macroporous hydrogel.

Natrix Introduces New Disposable mAb Purification Column

Eric Langer has over 25 years experience in biotechnology and life sciences strategic marketing management, market research, and publishing. He has held senior management and marketing positions at biopharmaceutical supply companies. He has published and authored many books and reports on topics in Biotechnology, Large-scale BioManufacturing, and bioscience commercialization and communication. He teaches at Johns Hopkins University marketing management, biotech marketing, services marketing, and marketing in a regulated environment. In 1989 he co-founded BioPlan Associates, Inc. to provide market analysis, and strategy to biotech and healthcare organizations.

More biopharma companies choose outside service providers for assay testing.

Assay Testing Shifts to Outsourced Operations

The divestment of Nimenrix and Mencevax was to satisfy regulatory clearances when GSK gained Novartis’ vaccines business in an asset swap in March 2015.

GSK Sells Two Meningitis Vaccines to Pfizer

ACG Worldwide discusses current and future uses of capsules in a video interview with Pharmaceutical Technology.

Trends in Pharmaceutical Capsules

L.B. Bohle discussed tablet coating in a video interview with Pharmaceutical Technology.

Expert Viewpoint on Tablet Coating

The agency clarifies its requirements for allowable excess volume and labeled vial fill size in injectables and biologics.

FDA Issues Guidance on Allowable Excess Volume for Injectables

Reach Separations has announced plans to double its laboratory space at its Nottingham facility as a result of increased demand for its specialist purification services.

Reach Separations Announces Major Expansion Initiative

Randi Hernandez was science editor at Pharmaceutical Technology from September 2014 to May 2017.

Monoclonal antibodies can facilitate the entry of radiopharmaceuticals into cells, David Scheinberg said at BIO 2015.

Using mAbs to Access Undruggable Targets

The agency takes action against websites that illegally sell unapproved medications.